Cargando…
High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient
We describe the case of a 5-year-old male who developed severe hyperactive delirium with aggressive violent behavior following the administration of IV levetiracetam for the treatment of status epilepticus on two occasions. The child's symptoms ranged from attacking his parents and the intensiv...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271000/ https://www.ncbi.nlm.nih.gov/pubmed/35818414 http://dx.doi.org/10.1155/2022/1843774 |
_version_ | 1784744584208711680 |
---|---|
author | Ward, Chad Khalid, Kiran Rozette, Nicole |
author_facet | Ward, Chad Khalid, Kiran Rozette, Nicole |
author_sort | Ward, Chad |
collection | PubMed |
description | We describe the case of a 5-year-old male who developed severe hyperactive delirium with aggressive violent behavior following the administration of IV levetiracetam for the treatment of status epilepticus on two occasions. The child's symptoms ranged from attacking his parents and the intensive care staff. Risperidone was given without any improvement in symptoms. A high-dose continuous infusion of IV dexmedetomidine was administered, and his violent behavior and delirium significantly improved. The two episodes of hyperactive delirium following IV levetiracetam administration occurred at ages 3 and 5, resulting in extensive work up including laboratory testing and cranial imaging, along with cerebral spinal fluid analysis and were normal. IV dexmedetomidine provided rapid symptom relief to prevent harm for the child, staff, and family on both occasions. |
format | Online Article Text |
id | pubmed-9271000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-92710002022-07-10 High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient Ward, Chad Khalid, Kiran Rozette, Nicole Case Rep Psychiatry Case Report We describe the case of a 5-year-old male who developed severe hyperactive delirium with aggressive violent behavior following the administration of IV levetiracetam for the treatment of status epilepticus on two occasions. The child's symptoms ranged from attacking his parents and the intensive care staff. Risperidone was given without any improvement in symptoms. A high-dose continuous infusion of IV dexmedetomidine was administered, and his violent behavior and delirium significantly improved. The two episodes of hyperactive delirium following IV levetiracetam administration occurred at ages 3 and 5, resulting in extensive work up including laboratory testing and cranial imaging, along with cerebral spinal fluid analysis and were normal. IV dexmedetomidine provided rapid symptom relief to prevent harm for the child, staff, and family on both occasions. Hindawi 2022-07-02 /pmc/articles/PMC9271000/ /pubmed/35818414 http://dx.doi.org/10.1155/2022/1843774 Text en Copyright © 2022 Chad Ward et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Ward, Chad Khalid, Kiran Rozette, Nicole High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient |
title | High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient |
title_full | High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient |
title_fullStr | High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient |
title_full_unstemmed | High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient |
title_short | High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient |
title_sort | high-dose dexmedetomidine for severe hyperactive delirium secondary to intravenous levetiracetam on two separate occasions in the same patient |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271000/ https://www.ncbi.nlm.nih.gov/pubmed/35818414 http://dx.doi.org/10.1155/2022/1843774 |
work_keys_str_mv | AT wardchad highdosedexmedetomidineforseverehyperactivedeliriumsecondarytointravenouslevetiracetamontwoseparateoccasionsinthesamepatient AT khalidkiran highdosedexmedetomidineforseverehyperactivedeliriumsecondarytointravenouslevetiracetamontwoseparateoccasionsinthesamepatient AT rozettenicole highdosedexmedetomidineforseverehyperactivedeliriumsecondarytointravenouslevetiracetamontwoseparateoccasionsinthesamepatient |